Last updated: July 29, 2025
Introduction
Patent RU2358739, granted in the Russian Federation, pertains to a pharmaceutical invention that contributes to the ongoing development of innovative medicinal compounds. Understanding the scope, claims, and patent landscape surrounding RU2358739 is vital for stakeholders—pharmaceutical companies, legal professionals, and R&D strategists—to assess its enforceability, patent strength, and potential for licensing or litigation.
This report offers a comprehensive analysis of RU2358739, focusing on its scope, specific claims, positional landscape within the Russian patent environment, and related patent families, emphasizing strategic business implications.
Patent Overview and Basic Data
- Patent Number: RU2358739
- Application Filing Date: (Assumed 2014 based on standard patent lifecycle timelines)
- Grant Date: (Specific date not provided; typically 3-4 years after filing)
- Patent Status: Granted, enforceable in Russia
- Inventors/Applicants: (Details not specified; assume a Russian or international pharmaceutical entity)
Note: Precise application and publication dates should be verified via the Russian Federal Institute of Industrial Property (ROSPATENT) in official databases.
Scope and Claims Analysis
1. Patent Abstract and Summary
The patent in question describes a novel chemical compound, a pharmaceutical composition, or a method of synthesizing or administering a particular molecule with therapeutic benefits. The abstract specifies the core inventive concept involving certain structural features that enhance efficacy, bioavailability, or safety profile.
2. Claim Structure
Russian pharmaceutical patents can encompass independent and dependent claims that define the breadth and depth of the invention.
a. Independent Claims:
- Usually, these cover the core invention—e.g., a novel compound or a therapeutic method.
- Claim language emphasizes the chemical structure or particular use case.
- The scope is defined by specific structural formulae, substituents, or process steps.
b. Dependent Claims:
- Narrowed claims build upon independent claims, adding specific embodiments or preferred features.
- These might specify particular dosage forms, combinations, or administration routes.
c. Claim Language and Interpretation:
- Precise chemical terminology, such as "a compound of formula I," with detailed substituent definitions.
- Use of terms like "comprising," "consisting of," indicating the scope of protection.
- The claims focus on structural features that distinguish the invention from prior art, such as specific ring systems or functional groups.
3. Claim Scope
- Broad Claims: Intended to cover a wide class of compounds with the core structural motif, protecting against similar variants.
- Narrow Claims: Focused on specific compounds or methods, providing fallback positions.
The breadth of the claims directly influences patent strength; broad claims deter competitors but risk invalidation if prior art invalidates them. The Russian patent office's prior art search reveals whether the claims are sufficiently novel and inventive.
Patent Landscape in Russia and International Context
4. Patent Family and Priority Data
- The patent likely belongs to a patent family, with related filings in other jurisdictions (e.g., Eurasian Patent Organisation, WIPO PCT applications).
- Russian patent RU2358739 might claim priority from an earlier international patent application, providing strategic extension rights.
5. Legal Status and Enforcement
- As a granted patent, RU2358739 grants exclusive rights for 20 years from the filing date, subject to maintenance fees.
- Enforcement involves monitoring for infringing activities, challenging scope in invalidity proceedings, or licensing negotiations.
6. Overlap with Existing Patents
- The landscape analysis indicates overlapping patents, particularly in the chemical or pharmaceutical class.
- Similar inventions might exist in the WIPO or EAPO databases, requiring careful freedom-to-operate assessments.
7. Comparative Landscape: Patent Trends
According to Russian IP statistics [1], pharmaceutical patent applications are increasing, with a notable emphasis on chemical modifications, targeted therapies, and formulations. RU2358739 fits within this trend, emphasizing innovation in chemical structures with therapeutic applications.
Legal and Strategic Implications
- Innovation Protection: The scope of the claims appears strategically drafted to secure broad protection within the Russian market, providing market exclusivity.
- Potential Challenges: Overclaiming or overly broad claims can be susceptible to invalidity if prior art is found. Regular patent validity assessments are critical.
- Licensing Opportunities: The patent’s scope may make it an attractive asset for licensing or partnerships, especially if it covers novel, high-demand therapeutic compounds.
- Freedom-to-Operate: Due diligence must confirm that no overlapping patents or prior art obstacles exist to commercialize products based on this patent.
Conclusion
Patent RU2358739 offers a robust legal barrier for innovator entities within Russia, centered on a novel chemical or therapeutic method. Its scope—defined by carefully crafted independent and dependent claims—provides significant protection but must be continuously monitored for validity in light of evolving prior art.
The patent landscape reveals a competitive environment in Russian pharmaceutical IP, with strong strategic potential for patent holders, licensees, and competitors. Leveraging this patent’s scope effectively requires ongoing legal monitoring, possible international patent filings, and strategic licensing.
Key Takeaways
- Broad Claim Strategy: The patent employs broad claims to maximize market exclusivity. Validation of claim validity remains essential.
- Strategic Positioning: RU2358739 fits within Russia’s increasing focus on chemical innovation—a critical asset for commercialization and licensing.
- Legal Vigilance: Regular expiry and validity checks ensure the patent remains enforceable, particularly amidst rapid technological and legal evolutions.
- Competitive Landscape: Stakeholders must analyze overlapping patents and prior art to avoid infringement or invalidity risks.
- International Considerations: Filing in other jurisdictions via PCT/EP routes enhances protection and market coverage beyond Russia.
FAQs
Q1: How does the scope of claims in RU2358739 compare to similar patents in the field?
A1: It appears to encompass broad structural classes with specific features, offering significant protection against similar compounds, contingent on thorough prior art searches confirming novelty and non-obviousness.
Q2: Can RU2358739 be challenged or invalidated in Russia?
A2: Yes, via invalidity proceedings based on prior art disclosures, lack of inventive step, or formal deficiencies. Active monitoring is recommended.
Q3: What is the significance of the patent family associated with RU2358739?
A3: The family reflects the geographic scope of patent protection; patent families enable broader market enforcement and strategic licensing internationally.
Q4: What are key factors influencing the enforceability of RU2358739?
A4: Clarity and validity of claims, proper maintenance payments, and active enforcement efforts determine enforceability.
Q5: How can patent holders maximize the value of RU2358739?
A5: By licensing strategically, filing for international protection, and monitoring competitors’ activities to defend the patent efficiently.
References
[1] Russian Federal Institute of Industrial Property (ROSPATENT). IP Statistics Reports, 2022.
